Article abstract


Nature Medicine 14, 656 - 666 (2008)
Published online: 25 May 2008 | doi:10.1038/nm1756

SUMOylation of Krüppel-like transcription factor 5 acts as a molecular switch in transcriptional programs of lipid metabolism involving PPAR-delta

Yumiko Oishi1,2, Ichiro Manabe1,3, Kazuyuki Tobe4,5, Mitsuru Ohsugi4, Tetsuya Kubota2,4, Katsuhito Fujiu1, Koji Maemura1, Naoto Kubota2,4, Takashi Kadowaki2,4 & Ryozo Nagai1


Obesity and metabolic syndrome are increasingly recognized as major risk factors for cardiovascular disease. Herein we show that Krüppel-like transcription factor 5 (KLF5) is a crucial regulator of energy metabolism. Klf5+/- mice were resistant to high fat–induced obesity, hypercholesterolemia and glucose intolerance, despite consuming more food than wild-type mice. This may in part reflect their enhanced energy expenditure. Expression of the genes involved in lipid oxidation and energy uncoupling, including those encoding carnitine-palmitoyl transferase-1b (Cpt1b) and uncoupling proteins 2 and 3 (Ucp2 and Ucp3), was upregulated in the soleus muscles of Klf5+/- mice. Under basal conditions, KLF5 modified with small ubiquitin-related modifier (SUMO) proteins was associated with transcriptionally repressive regulatory complexes containing unliganded peroxisome proliferator–activated receptor-delta (PPAR-delta) and co-repressors and thus inhibited Cpt1b, Ucp2 and Ucp3 expression. Upon agonist stimulation of PPAR-delta, KLF5 was deSUMOylated, and became associated with transcriptional activation complexes containing both the liganded PPAR-delta and CREB binding protein (CBP). This activation complex increased the expression of Cpt1b, Ucp2 and Ucp3. Thus, SUMOylation seems to be a molecular switch affecting function of KLF5 and the transcriptional regulatory programs governing lipid metabolism.

Top
  1. Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo, 7-3-1, Hongo, Bunkyo, Tokyo 113-8655, Japan.
  2. Clinical Nutrition Program, National Institute of Health and Nutrition, 1-23-1, Toyama, Shinjuku, Tokyo 162-8636, Japan.
  3. Nano-Bioengineering Education Program, Graduate School of Medicine, The University of Tokyo, 7-3-1, Hongo, Bunkyo, Tokyo 113-8655, Japan.
  4. Department of Metabolic Diseases, Graduate School of Medicine, The University of Tokyo, 7-3-1, Hongo, Bunkyo, Tokyo 113-8655, Japan.
  5. First Department of Internal Medicine, University of Toyama, 2630 Sugitani, Toyama 930-0194, Japan.

Correspondence to: Ichiro Manabe1,3Ryozo Nagai1 e-mail: manabe-tky@umin.ac.jp

Correspondence to: e-mail: nagai-tky@umin.ac.jp



MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated.

NEWS AND VIEWS

Multiple layers of metabolism

Nature Medicine News and Views (01 Jun 2008)

'PPAR'ting ways with inflammation

Nature Immunology News and Views (01 Oct 2005)


Extra navigation

Subscribe to Nature Medicine

Subscribe

Open Innovation Challenges

ADVERTISEMENT